European Union regulatory frameworks are designed to provide stability, predictability, and coherence across Member States. Directives such as the Tobacco Products Directive (TPD) and the Tobacco Excise Directive (TED) are central to this approach, establishing the rules that govern how tobacco and nicotine products are regulated and taxed across the internal market.
These frameworks are not revised frequently. When changes do occur, they often shape the regulatory and public health landscape for many years. As a result, the current review processes for both the TPD and TED represent a significant moment for policymakers to assess how these directives influence behaviour, market dynamics, and long-term health outcomes.
Long Policy Cycles and Lasting Impact
EU directives are typically the result of extended legislative processes involving consultation, negotiation, and compromise across institutions and Member States. Once adopted, they provide a stable regulatory foundation that can remain in place for a decade or more.
This long policy cycle is designed to ensure consistency and allow markets and regulatory systems to adapt. However, it also means that the consequences of regulatory decisions may not be fully visible until years after implementation.
Johan Nissinen, former Member of the European Parliament and now working with the Global Institute for Novel Nicotine (GINN), has reflected on this dynamic based on his experience with EU legislative processes.
“One of the unusual aspects of working on EU directives is that you rarely see their full impact yourself,” Nissinen noted in discussions with GINN. “The effects tend to appear years later, in everyday behaviour.”
This delayed impact highlights the importance of considering not only the immediate regulatory objectives of a directive but also its longer-term influence on consumer behaviour and public health outcomes.
The Role of TPD and TED in Shaping Behaviour
The TPD and TED operate in different but complementary ways.
The Tobacco Products Directive establishes rules related to product standards, packaging, labelling, and market access. It defines how different categories of tobacco and nicotine products are regulated within the European Union.
The Tobacco Excise Directive, by contrast, governs taxation. It sets minimum excise levels and provides a framework for how Member States apply taxes to tobacco products, influencing retail prices and consumer purchasing decisions.
Together, these directives shape both the availability of products and the economic incentives associated with their use. For individuals who smoke or use nicotine products, these policy signals are experienced simultaneously.
As a result, the combined effect of regulatory and fiscal frameworks plays a significant role in influencing patterns of consumption over time.
Incentives and Policy Design
Public health policy often relies on a combination of regulatory restrictions and economic incentives to influence behaviour. In tobacco control, this includes measures such as product standards, marketing limitations, and excise taxation.
The effectiveness of these measures depends in part on how they interact. Regulatory frameworks that align with behavioural incentives may help guide individuals toward less harmful outcomes. Conversely, when policy signals are unclear or inconsistent, behavioural change may be slower or less predictable.
Nissinen has emphasised the importance of this alignment when considering the long-term impact of current policy decisions.
“TPD and TED are exactly that kind of file,” he observed. “They are slow to revise, but their effects last a long time. The choices made now will shape patterns of behaviour for years.”
This perspective reflects a broader principle in public health policy: regulatory decisions should take into account not only immediate objectives but also how incentives influence behaviour over extended periods.
A Changing Nicotine Landscape
The context in which the TPD and TED operate has evolved significantly since their earlier iterations. The European nicotine market now includes a wider range of products, including non-combustible alternatives to traditional cigarettes.
Scientific and regulatory discussions increasingly recognise that these products may differ in their risk profiles compared to combustible tobacco. At the same time, policymakers continue to prioritise measures that prevent youth initiation and protect public health.
As the product landscape becomes more diverse, the design of regulatory and fiscal frameworks becomes more complex. Policymakers must consider how different tools, such as product regulation and taxation, interact within this evolving environment.
The Importance of Getting Incentives Right
In long-term policy frameworks, incentives play a critical role in shaping outcomes.
Price signals, regulatory classifications, and product availability all influence how individuals make decisions about nicotine use. These factors do not operate in isolation; they form part of a broader environment that shapes behaviour over time.
Nissinen highlighted this point in the context of ongoing policy discussions:
“The choices we make now will lock in patterns for a long time,” he said. “That is why getting the incentives right matters.”
This statement reflects the importance of considering how regulatory and fiscal measures work together to support public health objectives. Policies that align incentives with desired outcomes may be more effective in reducing smoking-related harm over the long term.
Looking Ahead
The revision of the Tobacco Products Directive and the Tobacco Excise Directive offers a rare opportunity to reassess how EU policy frameworks influence both markets and behaviour.
Given the long lifespan of these directives, decisions made during this review process will have lasting implications. They will shape how products are regulated, how they are priced, and how policy signals are communicated to consumers across the European Union.
For policymakers, the challenge is to ensure that these frameworks remain aligned with current scientific evidence and behavioural realities, while continuing to provide strong protections for public health.
As experience has shown, the full impact of these decisions may only become visible over time. Ensuring that regulatory and fiscal incentives are carefully considered today may therefore be critical to achieving meaningful public health outcomes in the years ahead.
